All PROs significantly higher for those discontinuing TNFi at week 12 vs week 0, but not at later time points.

HealthDay News — More than half of children younger than 5 years exposed to hepatitis B virus (HBV) are exposed by someone in their household other than their birth mother, according to a study ...

Compared with the placebo group, the 400mg group had significantly higher percentages of participants with clinical remission at week 12. HealthDay News — For patients with moderately to severely ...

HealthDay News — For patients with atrial fibrillation (AF) and prior intracranial bleeding, direct oral anticoagulants (DOACs) are associated with a reduced risk for ischemic stroke (IS) and death, ...

Interim data from the open-label phase 3 MagnetisMM-32 study demonstrate a significant progression free survival benefit with elranatamab monotherapy vs active standard regimens in patients previously ...

Topline phase 3 data show tradipitant significantly reduced semaglutide-associated vomiting and severe nausea in adults with ...

HealthDay News — Treating depression with interpersonal psychotherapy during pregnancy influences infant brain development ...

HealthDay News — Early uptake was rapid for oral semaglutide (Wegovy pill) relative to injectable incretin-based weight ...

Adults with moderately to severely active Crohn disease can now self-administer risankizumab induction at home using an ...

Mean percentage of time that CGM-measured glucose level was in range of 70 to 180mg/dL was 21 percentage points higher with CGM ...

HealthDay News — Medical device adverse event reports are frequently incomplete, inaccurate, and delayed, according to a study published online October 14 in The BMJ.

The new 150mg oral pellet formulation provides a capsule-free prophylactic option for adults and adolescents with hereditary ...